Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos Raises $430K through Warrants Exercise

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Belgian drug discovery company Galapagos today announced it increased its shares capital by about €350,000 ($430,000) through the exercise of employee warrants.

The firm issued 40,160 new ordinary shares today for an average of €8.71 per share. Following today's capital increase, the company has a share capital of more than €129 million with a total of almost 24 million shares outstanding.

Galapagos uses warrant plans to "incentivize personnel and management and have them share in the success of the company," it said in a statement. The company added that no board members or executive members exercised warrants in the round.

The company also announced that it has received a transparency notification indicating that an individual identified as A. Strating, as well as companies TWE Beheer, TWE Investment, and Gestion Deelnemingen V combined hold nearly 1.3 million shares, or 5.25 percent of Galapagos' shares.

Gestion previously notified Galapagos that it held almost 1.2 million shares, or 5.02 percent of the company's shares.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.